Shu Yu Civilian Pharmacy Corp., Ltd. Class A

Shu Yu Civilian Pharmacy Corp., Ltd. Class A

SSZSE:301017
12.80
CNY
-0.45
(-3.40%)
0.13EPS
215.42P/E
6.02BMarket Cap
May 05Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
7.3
9.14
15.41
14.99
7.8
8.41
9.35
12.65
13.89
19.44
22.79
23.82
25.31
27.79
Basic EPS, GAAP
0.33
0.51
0.32
0.71
0.37
0.33
0.3
0.59
0.3
0.57
0.33
-0.47
0.28
0.07
Free Cash Flow per Basic Share
- -
- -
- -
- -
0.12
-0.06
0.02
0.11
0.26
0.09
-0.1
0.79
1.55
- -
Dividend per Share
0.03
0.12
0.99
- -
0.05
0.01
0.06
0.06
0.15
0.17
0.27
0.26
0.22
0.29
Book Value per Share
1.32
1.72
2.22
2.95
4.78
3.36
3.61
4.17
4.66
5.5
5.65
5.03
5.26
5.18
Tangible Book Value per Share
1.31
1.47
1.54
1.58
2.95
2.67
2.58
3.12
2.85
2.82
1.92
0.39
-0.69
-0.86
Basic Weighted Avg Shares
130
130
102
130
318
343
371
367
383
403
403
402
408
390
Sales/Revenue/Turnover
949
1,188
1,566
1,943
2,483
2,888
3,467
4,640
5,322
7,823
9,191
9,570
10,327
10,852
Operating Margin (%)
6.58
7.84
6.22
6.74
6.83
6.11
100
7.1
3.5
5.35
3.68
0.26
2.17
2.48
Depreciation Expense
- -
- -
- -
- -
17
17
31
39
262
373
510
483
414
- -
Net Income, GAAP
43
67
33
92
118
113
111
216
115
229
133
-189
114
27
Effective Tax Rate (%)
33.88
28.42
52.51
30.31
32.1
35.48
32.96
24.97
24.02
27.24
21.14
- -
31.92
42.41
Profit Margin (%)
4.54
5.63
2.08
4.74
4.74
3.93
3.21
4.66
2.16
2.93
1.45
-1.97
1.11
0.25
Working Capital
92
120
108
45
259
471
412
241
107
766
247
-41
-527
-621
LT Debt
- -
- -
- -
- -
68
- -
- -
251
433
1,361
1,671
1,683
1,438
1,377
Total Equity
171
226
291
392
664
1,231
1,326
1,530
1,914
2,267
2,366
2,125
2,293
2,254
Return on Invested Capital (%)
- -
30.14
10.37
21.55
16.31
10.6
7.88
12.02
5.02
5.58
2.71
- -
2.21
0.96
Return on Capital (%)
- -
34.39
13.71
24.41
20.65
11.53
8.82
12.79
5.38
6.66
3.83
- -
3.45
1.38
Return on Common Equity (%)
- -
33.91
12.7
27.26
22.55
12.02
8.74
15.25
6.74
11.14
5.88
-8.72
5.48
1.29

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
1,869
1,828
1,786
LT Borrowings
1,229
1,170
1,172
LT Finance Leases
247
223
205
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
406
406
406
Market Capitalization
5,853
5,289
6,019

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
5,451
5,320
5,470
Cash, Cash Equivalents & STI
1,462
1,463
1,657
Accounts Receivable, Net
1,091
1,145
1,114
Inventories
1,961
1,841
1,850
Total Current Liabilities
5,926
5,956
6,091
Payables & Accruals
- -
- -
- -
ST Debt
1,869
1,828
1,786
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
25.8%
9.13%
7.92%
Free Cash Flow
- -
-186.45%
99.66%
Net Income, GAAP
-9.18%
-78.33%
-160.5%
Sales/Revenue/Turnover
21.33%
18.25%
7.91%
Total Cash Common Dividend
416.85%
44.92%
-12.35%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2,439
2,379
2,260
2,492
9,570
2025
2,379
2,503
- -
2,882
10,327
2026
2,601
2,712
2,657
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.03
0.03
-0.09
-0.44
-0.47
2025
0.06
0.03
- -
0.01
0.28
2026
0.03
0.04
-0.01
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.06
0.05
0.1
0.06
0.26
2025
0.05
0.05
- -
0.07
0.22
2026
0.06
0.1
0.05
- -
- -

Company Description

CEO
Guang Xia Qin
Full Time Employees
15,933
Sector
Retail trade
Industry
Drugstore chains
Address
Jinan China
IPO Date
Jul 5, 2021
Business
Shu Yu Civilian Pharmacy Corp., Ltd. is a China-based retail and wholesale pharmacy chain operator primarily engaged in the distribution and retail sale of pharmaceuticals, healthcare products, and medical devices. Founded in 2002 and headquartered in Jinan, Shandong Province, the company operates retail pharmacy networks, specialized Direct-to-Patient pharmacies, community medical clinics, and modern pharmaceutical logistics distribution centers across the People's Republic of China. The company operates through integrated retail and wholesale channels, offering a comprehensive portfolio of products and services that comprises western pharmaceuticals and chemical drugs, covering cardiovascular, anti-infective, endocrine, gastrointestinal, respiratory, and oncology therapeutic categories; traditional Chinese medicines, including proprietary Chinese patent drugs, processed herbal decoction pieces, and wellness tonics; healthcare and nutritional supplements, including vitamins, dietary minerals, sports nutrition, and functional health foods; medical devices and home diagnostic equipment, such as sphygmomanometers, blood glucose meters, rehabilitation aids, surgical dressings, and personal protective gear; personal care and daily consumer goods, including cosmeceuticals, maternal and infant care supplies, oral care products, and household sanitation items; and clinical healthcare services, comprising licensed pharmacist medication counseling, chronic disease health management, prescription review, medical insurance dual-channel reimbursement fulfillment, Direct-to-Patient specialty drug distribution, and omnichannel online-to-offline on-demand delivery services. Shu Yu Civilian Pharmacy Corp., Ltd. primarily serves retail consumers, chronic disease patients, and regional healthcare institutions, maintaining a dominant market position in Shandong Province while expanding operations across northern, northeastern, and central China, including Liaoning, Henan, Heilongjiang, Fujian, and Shaanxi provinces. In recent developments, the company has actively executed an external expansion strategy by acquiring controlling interests in multiple regional retail pharmacy chains and asset portfolios across northern and northeastern China to increase store density and market share. Additionally, the company has accelerated its digital transformation by expanding partnerships with leading third-party instant-delivery e-commerce platforms, upgrading proprietary digital membership and remote prescription inquiry systems, and expanding its network of medical insurance dual-channel designated pharmacies to capture outpatient prescription outflow from public hospitals. To support ongoing retail scale expansion, the company has continued to modernize its automated pharmaceutical logistics centers and optimize its supply chain distribution capabilities.